General - Press Releases

Date	Title	Company
20-Jul-2023	MaaT Pharma Joins Microbiome Therapeutics Innovation Group	Businesswire
20-Jul-2023	TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities	Businesswire
20-Jul-2023	Mauna Kea Technologies annonce son chiffre d’affaires pour le 2ème trimestre et le 1er semestre 2023	Businesswire
20-Jul-2023	Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue	Businesswire
20-Jul-2023	CEL-SCI Announces Closing of Public Offering	Businesswire
20-Jul-2023	Emergence of Multidrug-Resistant Strains Steers Global Tuberculosis Therapeutics Market Towards $2.99 Billion by 2030 - ResearchAndMarkets.com	Businesswire
20-Jul-2023	LinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses	Businesswire
20-Jul-2023	$6.5+ Billion MRD (Minimal Residual Disease) Testing Market - Global and Regional Analysis and Forecasts to 2033 - Revolutionary Technologies Transform MRD Testing Market for Cancer Patients - ResearchAndMarkets.com	Businesswire
20-Jul-2023	European Flow Chemistry Summit 2024: From Lab to Industry - Explore the Cutting-edge Applications (Rotterdam, Netherlands - March 25-26, 2024) - ResearchAndMarkets.com	Businesswire
20-Jul-2023	Dalrada Pharmaceutical Subsidiary, Watson Rx Solutions, Earns Prestigious NABP Specialty Pharmacy and Digital Pharmacy Accreditation	Businesswire
20-Jul-2023	Qosina Introduces Aramus™ 2D Bag Chambers from Entegris to Its Bioprocess Components Portfolio	Businesswire
20-Jul-2023	n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients	Businesswire
20-Jul-2023	Sangamo Therapeutics and Chroma Medicine Announce Option and License Agreement to Evaluate and Develop Zinc Finger Proteins for Epigenetic Editing	Businesswire
20-Jul-2023	Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema	Businesswire
20-Jul-2023	GeneCentric Therapeutics Announces Publication of New Results Showing Clinical Benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to Guide Lung Cancer Treatment Selection	Businesswire
20-Jul-2023	Alternative Asset Manager HighVista Strategies LLC to Acquire abrdn’s U.S. Private Markets Business	Businesswire
20-Jul-2023	Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets	Businesswire
20-Jul-2023	Revvity Accelerates NGS Library Prep with Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC	Businesswire
20-Jul-2023	Suono Bio Reports Encouraging Results From a First in Human (FiH) Study of Its Ultrasound Mediated Drug Delivery Platform	Businesswire
20-Jul-2023	EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million	Businesswire